146 filings
Page 2 of 8
8-K
b2lk8y8 yzvvhpu4n
3 Aug 22
Submission of Matters to a Vote of Security Holders
4:10pm
8-K
4hi3n3v5
7 Jul 22
Amendments to Articles of Incorporation or Bylaws
4:33pm
8-K
pc6 mwzpqaqy5rx
28 Jun 22
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:10pm
8-K
ias03skknsjs
20 May 22
Corporate Updates May 2022
4:12pm
8-K
m072zgu 9d
25 Apr 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:13pm
8-K
az9cd5q4w fwuthfa4
15 Apr 22
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:27pm
8-K/A
0jwnx0f70tpyymgfz
1 Mar 22
Departure of Directors or Certain Officers
4:10pm
8-K
iur5m
25 Feb 22
Departure of Directors or Certain Officers
12:00am
8-K
xbmnrm lhi782iub7
16 Feb 22
Changes in Registrant's Certifying Accountant
4:50pm
8-K
au1l 0h3l5f722
11 Jan 22
ZIVO Bioscience Names Chairman John B. Payne as President and CEO
12:00am
8-K/A
tr894o1c5 7r
10 Dec 21
Changes in Registrant's Certifying Accountant
12:00am
8-K
1v8ku6428i34nqf10w
9 Dec 21
Changes in Registrant's Certifying Accountant
6:01am
8-K
kry1jsoq6pl9fb34j4l3
14 Oct 21
Submission of Matters to a Vote of Security Holders
8:51am
8-K
n96 wu42al03xqhllt4
12 Oct 21
Regulation FD Disclosure
9:32am
8-K
fls233gnvk05z3ts
21 Sep 21
Departure of Directors or Certain Officers
4:15pm
8-K/A
wonvtvvs gba9v
16 Sep 21
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
goe1x 45lv0iwrnpb3j
2 Jun 21
Zivo Bioscience, Inc. Announces Pricing of Upsized $13.8 Million Public Offering and Up-listing to Nasdaq
5:14pm
8-K
tf62i
17 Mar 21
Regulation FD Disclosure
9:57am
8-K
hkf84 rwn3xk
12 Feb 21
Departure of Directors or Certain Officers
4:34pm
8-K
4mnye qfr5y
7 Jan 21
Zivo Bioscience Names Keith R. Marchiando As Chief Financial Officer
5:02pm